NYSE · Medical - Diagnostics & Research

DGX (DGX) Stock

$236.22 -1.70% NYSE: DGX Healthcare

Valuation

MetricValue
Price$236.22
Market Cap$26.07B
P/E Ratio21.70
P/B Ratio2.93
P/S Ratio1.90
EPS (TTM)$8.75
52-Week High$246.37
52-Week Low$164.65
Dividend Yield1.68%

Financials & Margins

MetricValue
ROE13.84%
ROA6.11%
ROCE22.00%
Gross Margin14.53%
Operating Margin14.53%
Net Margin9.08%
Debt/Equity0.95
Current Ratio1.04

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.8B$9.9B$9.3B$9.9B$11.0B
Operating Profit$2.4B$1.4B$1.3B$1.3B$1.6B
Net Profit$2.0B$946.0M$854.0M$871.0M$992.0M
EPS$15.53$7.98$7.52$7.69$8.75
Op Margin22.1%14.4%13.6%13.6%14.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.6B$12.8B$14.0B$16.2B$16.2B
Total Liabilities$7.0B$6.8B$7.6B$9.3B$8.9B
Cash$872.0M$315.0M$686.0M$549.0M$420.0M
Borrowings$4.8B$4.7B$5.5B$7.1B$6.9B

Latest News

Leerink Partners Adjusts Quest Diagnostics Price Target to $244 From $240, Maintains Outperform Rating MT Newswires · Jul 15, 2026 Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus Zacks · Jul 14, 2026 Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now? Zacks · Jul 14, 2026 One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns PR Newswire · Jul 10, 2026 More U.S. Workers Are Testing Positive for Marijuana. Fewer Employers Are Concerned. The Wall Street Journal · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.2B$1.7B$1.3B$1.3B$1.9B
Investing Cash Flow$-382.0M$-947.0M$-1.5B$-3.0B$-1.2B
Financing Cash Flow$-2.2B$-1.4B$-274.0M$-128.0M$-512.0M
Net Cash Flow$-286.0M$-557.0M$371.0M$-137.0M$-129.0M
Free Cash Flow$1.8B$1.3B$864.0M$909.0M$1.4B

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA12.66
FCF Yield6.18%
Quick Ratio1.08
Interest Coverage6.07
Return 1Y37.85%
Return 3Y94.45%
Return 5Y81.04%

Ownership

Insiders Held0.43%
Institutions Held98.03%
Institutions Float Held98.45%
Institutional HolderSharesReport Date
Blackrock Inc.9,172,2922026-03-31
Vanguard Capital Management LLC7,145,6722026-03-31
Price (T.Rowe) Associates Inc6,297,9872026-03-31
Vanguard Portfolio Management LLC6,081,4002026-03-31
State Street Corporation5,380,8212026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ICLR $161.40 -2.18% 11.92 $12.36B 0.00%
ILMN $207.13 -3.04% 41.56 $31.34B 0.00%
INCY $125.01 +1.45% 15.30 $25.34B 0.00%
LH $327.61 -1.52% 24.43 $26.86B 1.12%
MEDP $583.21 -1.81% 34.20 $16.28B 0.00%

About DGX

DGX is led by CEO James E. Davis, employs 57,000 people, headquartered in Secaucus, US, publicly traded since 1996.

DGX stock trades at $236.22 with a market capitalization of $26.07B. The stock is valued at a price-to-earnings (P/E) ratio of 21.70, price-to-book of 2.93, price-to-sales of 1.90. Over the past 52 weeks the stock has ranged between $164.65 and $246.37, and currently trades 4.1% below its 52-week high. It pays a dividend yielding 1.68%.

On profitability, DGX generates a return on equity (ROE) of 13.84%, above the typical market average, return on capital employed of 22.00%, an operating margin of 14.53%, a net profit margin of 9.08%.

In its most recent fiscal year, DGX reported annual revenue of $11.0B, net profit of $992.0M, revenue has compounded at 3.2% a year over the last five years, profit at -7.1% a year.

The balance sheet shows a debt-to-equity ratio of 0.95, a current ratio of 1.04, total assets of $16.2B, $420.0M in cash and equivalents.

DGX has a beta of 0.59 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides